---
title: "Empagliflozin - Diabetes Mellitus Type 2"
sidebar: mydoc_sidebar
permalink: db09038-mesh-d003924-1.html
toc: false 
---


Path ID: `DB09038_MESH_D003924_1`
{% include image.html url="images/db09038-mesh-d003924-1.png" file="db09038-mesh-d003924-1.png" alt="db09038-mesh-d003924-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C570240 | Empagliflozin | Drug |
| UniProt:P31639 | Sodium/glucose cotransporter 2 | Protein |
| GO:0035623 | Renal glucose absorption | BiologicalProcess |
| HP:0003076 | Glycosuria | PhenotypicFeature |
| MESH:D001786 | Blood Glucose | ChemicalSubstance |
| MESH:D003924 | Diabetes mellitus type 2 | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Empagliflozin | DECREASES ACTIVITY OF | Sodium/Glucose Cotransporter 2 |
| Sodium/Glucose Cotransporter 2 | NEGATIVELY REGULATES | Renal Glucose Absorption |
| Renal Glucose Absorption | HAS PHENOTYPE | Glycosuria |
| Glycosuria | DECREASES ABUNDANCE OF | Blood Glucose |
| Blood Glucose | CORRELATED WITH | Diabetes Mellitus Type 2 |
|---------|-----------|---------|

Comment: Empagliflozin is used in combination with proper diet and exercise

Reference: 
  - [https://go.drugbank.com/drugs/DB09038#mechanismofaction](https://go.drugbank.com/drugs/DB09038#mechanismofaction)
